Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

News

Author: Pippa Prendergast-CoatesPublished: 6 August 2020

Prep: Cook: Serves:

Close up woman holding pill in hand with water. Female going to take tablet from headache, painkiller, medication drinking clear water from glass. Healthcare, medicine, treatment, therapy concept

A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition.

As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s.

The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be conducted to find the optimal use.

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the Parkinson’s Europe website.

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Parkinson’s in the news: June

We round up the top Parkinson’s news stories from around the globe

Parkinson’s prevalence expected to increase by 18% in next seven years

Aging UK population could see increase in Parkinson’s over time

Tickets on sale for ‘Insight into Parkinson’s’ summit 2019

Tickets for the online event are now on sale

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…

Study explores predictors of cognitive impairment in Parkinson’s disease

Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.

Could frailty be a potential risk factor for Parkinson’s disease?

Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

News

Author: Pippa Prendergast-CoatesPublished: 6 August 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Parkinson’s in the news: June

Special reports

Parkinson’s prevalence expected to increase by 18% in next seven years

Global update

Tickets on sale for ‘Insight into Parkinson’s’ summit 2019

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

News

Author: Pippa Prendergast-CoatesPublished: 6 August 2020

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Parkinson’s in the news: June

Special reports

Parkinson’s prevalence expected to increase by 18% in next seven years

Global update

Tickets on sale for ‘Insight into Parkinson’s’ summit 2019

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

Sign in